Biopharmaceutical CMO And CRO Market 2027 by Source, Service Type, Product and Geography | The Insight Partners

Biopharmaceutical CMO And CRO Market to 2027 - Global Analysis and Forecasts By Source (Mammalian and Non-Mammalian); Service Type (Contract Manufacturing and Contract Research); Product (Biologics and Biosimilars) and Geography

Report Code: TIPRE00007162 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming
MARKET INTRODUCTION

A contract research organization (CRO) is a company that offers services to the pharmaceutical and biotechnology industries. These companies partner with various companies and organize and conduct clinical trials to test the new molecule before obtaining approval. Contract manufacturing organizations (CMO) offer manufacturing services, with volume capabilities ranging from small amounts for preclinical R&D to larger volumes necessary for clinical trial purposes and commercialization.

MARKET DYNAMICS

The biopharmaceutical CMO and CRO market is anticipated to grow in the forecast, owing to increasing R&D expenditures and outsourcing activities, along with rise in the number of clinical trials. In addition, growing demand for biosimilars and biologics is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Biopharmaceutical CMO and CRO Market Analysis to 2027" is a specialized and in-depth study of the healthcare IT industry with a special focus on the global market trend analysis. The report aims to provide an overview of biopharmaceutical CMO and CRO market with detailed market segmentation by source, service type, product, and geography. The biopharmaceutical CMO and CRO market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading biopharmaceutical CMO and CRO market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The biopharmaceutical CMO and CRO market is segmented on the basis of source, service type and product. Based on source the market is segmented as, mammalian and non-mammalian. On the basis of service type the market is categorized as, contract manufacturing and contract research. Based on product, the market is classified as, biologics and biosimilars.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Biopharmaceutical CMO and CRO market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Biopharmaceutical CMO and CRO market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Biopharmaceutical CMO and CRO market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Biopharmaceutical CMO and CRO market in these regions.

MARKET PLAYERS

The report covers key developments in the Biopharmaceutical CMO and CRO market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Biopharmaceutical CMO and CRO market are anticipated to have lucrative growth opportunities in the future with the rising demand for Biopharmaceutical CMO and CRO market in the global market. Below mentioned is the list of few companies engaged in the Biopharmaceutical CMO and CRO market.

The report also includes the profiles of key Biopharmaceutical CMO and CRO market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  AGC Biologics
  •  Boehringer Ingelheim International GmbH
  •  FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  •  Inno Bio Ventures Sdn Bhd
  •  JRS PHARMA
  •  Lonza
  •  PRA Health Sciences, Inc.
  •  ProBioGen AG
  •  Rentschler Biopharma SE
  •  Samsung BioLogics

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biopharmaceutical CMO And CRO Market - By Source
1.3.2 Biopharmaceutical CMO And CRO Market - By Service Type
1.3.3 Biopharmaceutical CMO And CRO Market - By Product
1.3.4 Biopharmaceutical CMO And CRO Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOPHARMACEUTICAL CMO AND CRO MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOPHARMACEUTICAL CMO AND CRO MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOPHARMACEUTICAL CMO AND CRO MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOPHARMACEUTICAL CMO AND CRO - GLOBAL MARKET OVERVIEW
6.2. BIOPHARMACEUTICAL CMO AND CRO - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BIOPHARMACEUTICAL CMO AND CRO MARKET - REVENUE AND FORECASTS TO 2027 - SOURCE
7.1. OVERVIEW
7.2. SOURCE MARKET FORECASTS AND ANALYSIS
7.3. MAMMALIAN
7.3.1. Overview
7.3.2. Mammalian Market Forecast and Analysis
7.4. NON-MAMMALIAN
7.4.1. Overview
7.4.2. Non-Mammalian Market Forecast and Analysis
8. BIOPHARMACEUTICAL CMO AND CRO MARKET - REVENUE AND FORECASTS TO 2027 - SERVICE TYPE
8.1. OVERVIEW
8.2. SERVICE TYPE MARKET FORECASTS AND ANALYSIS
8.3. CONTRACT MANUFACTURING
8.3.1. Overview
8.3.2. Contract Manufacturing Market Forecast and Analysis
8.3.3. Analytical and QC studies Market
8.3.3.1. Overview
8.3.3.2. Analytical and QC studies Market Forecast and Analysis
8.3.4. Fill and Finish Operations Market
8.3.4.1. Overview
8.3.4.2. Fill and Finish Operations Market Forecast and Analysis
8.3.5. Packaging Market
8.3.5.1. Overview
8.3.5.2. Packaging Market Forecast and Analysis
8.3.6. Process Development Market
8.3.6.1. Overview
8.3.6.2. Process Development Market Forecast and Analysis
8.4. CONTRACT RESEARCH
8.4.1. Overview
8.4.2. Contract Research Market Forecast and Analysis
8.4.3. Cardiology Market
8.4.3.1. Overview
8.4.3.2. Cardiology Market Forecast and Analysis
8.4.4. Inflammation and Immunology Market
8.4.4.1. Overview
8.4.4.2. Inflammation and Immunology Market Forecast and Analysis
8.4.5. Neuroscience Market
8.4.5.1. Overview
8.4.5.2. Neuroscience Market Forecast and Analysis
8.4.6. Oncology Market
8.4.6.1. Overview
8.4.6.2. Oncology Market Forecast and Analysis
8.4.7. Other Types Market
8.4.7.1. Overview
8.4.7.2. Other Types Market Forecast and Analysis
9. BIOPHARMACEUTICAL CMO AND CRO MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
9.1. OVERVIEW
9.2. PRODUCT MARKET FORECASTS AND ANALYSIS
9.3. BIOLOGICS
9.3.1. Overview
9.3.2. Biologics Market Forecast and Analysis
9.3.3. Antisense RNAi Market
9.3.3.1. Overview
9.3.3.2. Antisense RNAi Market Forecast and Analysis
9.3.4. and Molecular Therapy Market
9.3.4.1. Overview
9.3.4.2. and Molecular Therapy Market Forecast and Analysis
9.3.5. Monoclonal Antibodies (MAbs) Market
9.3.5.1. Overview
9.3.5.2. Monoclonal Antibodies (MAbs) Market Forecast and Analysis
9.3.6. Recombinant Proteins Market
9.3.6.1. Overview
9.3.6.2. Recombinant Proteins Market Forecast and Analysis
9.3.7. Vaccines Market
9.3.7.1. Overview
9.3.7.2. Vaccines Market Forecast and Analysis
9.3.8. Other Biologics Market
9.3.8.1. Overview
9.3.8.2. Other Biologics Market Forecast and Analysis
9.4. BIOSIMILARS
9.4.1. Overview
9.4.2. Biosimilars Market Forecast and Analysis
10. BIOPHARMACEUTICAL CMO AND CRO MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Biopharmaceutical CMO And CRO Market Overview
10.1.2 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.1.3 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.1.4 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.1.5 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.1.6 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.1.6.1 United States Biopharmaceutical CMO And CRO Market
10.1.6.1.1 United States Biopharmaceutical CMO And CRO Market by Source
10.1.6.1.2 United States Biopharmaceutical CMO And CRO Market by Service Type
10.1.6.1.3 United States Biopharmaceutical CMO And CRO Market by Product
10.1.6.2 Canada Biopharmaceutical CMO And CRO Market
10.1.6.2.1 Canada Biopharmaceutical CMO And CRO Market by Source
10.1.6.2.2 Canada Biopharmaceutical CMO And CRO Market by Service Type
10.1.6.2.3 Canada Biopharmaceutical CMO And CRO Market by Product
10.1.6.3 Mexico Biopharmaceutical CMO And CRO Market
10.1.6.3.1 Mexico Biopharmaceutical CMO And CRO Market by Source
10.1.6.3.2 Mexico Biopharmaceutical CMO And CRO Market by Service Type
10.1.6.3.3 Mexico Biopharmaceutical CMO And CRO Market by Product
10.2. EUROPE
10.2.1 Europe Biopharmaceutical CMO And CRO Market Overview
10.2.2 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.2.3 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.2.4 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.2.5 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.2.6 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Biopharmaceutical CMO And CRO Market
10.2.6.1.1 Germany Biopharmaceutical CMO And CRO Market by Source
10.2.6.1.2 Germany Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.1.3 Germany Biopharmaceutical CMO And CRO Market by Product
10.2.6.2 France Biopharmaceutical CMO And CRO Market
10.2.6.2.1 France Biopharmaceutical CMO And CRO Market by Source
10.2.6.2.2 France Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.2.3 France Biopharmaceutical CMO And CRO Market by Product
10.2.6.3 Italy Biopharmaceutical CMO And CRO Market
10.2.6.3.1 Italy Biopharmaceutical CMO And CRO Market by Source
10.2.6.3.2 Italy Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.3.3 Italy Biopharmaceutical CMO And CRO Market by Product
10.2.6.4 Spain Biopharmaceutical CMO And CRO Market
10.2.6.4.1 Spain Biopharmaceutical CMO And CRO Market by Source
10.2.6.4.2 Spain Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.4.3 Spain Biopharmaceutical CMO And CRO Market by Product
10.2.6.5 United Kingdom Biopharmaceutical CMO And CRO Market
10.2.6.5.1 United Kingdom Biopharmaceutical CMO And CRO Market by Source
10.2.6.5.2 United Kingdom Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.5.3 United Kingdom Biopharmaceutical CMO And CRO Market by Product
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Biopharmaceutical CMO And CRO Market Overview
10.3.2 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.3.3 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.3.4 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.3.5 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.3.6 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Biopharmaceutical CMO And CRO Market
10.3.6.1.1 Australia Biopharmaceutical CMO And CRO Market by Source
10.3.6.1.2 Australia Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.1.3 Australia Biopharmaceutical CMO And CRO Market by Product
10.3.6.2 China Biopharmaceutical CMO And CRO Market
10.3.6.2.1 China Biopharmaceutical CMO And CRO Market by Source
10.3.6.2.2 China Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.2.3 China Biopharmaceutical CMO And CRO Market by Product
10.3.6.3 India Biopharmaceutical CMO And CRO Market
10.3.6.3.1 India Biopharmaceutical CMO And CRO Market by Source
10.3.6.3.2 India Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.3.3 India Biopharmaceutical CMO And CRO Market by Product
10.3.6.4 Japan Biopharmaceutical CMO And CRO Market
10.3.6.4.1 Japan Biopharmaceutical CMO And CRO Market by Source
10.3.6.4.2 Japan Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.4.3 Japan Biopharmaceutical CMO And CRO Market by Product
10.3.6.5 South Korea Biopharmaceutical CMO And CRO Market
10.3.6.5.1 South Korea Biopharmaceutical CMO And CRO Market by Source
10.3.6.5.2 South Korea Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.5.3 South Korea Biopharmaceutical CMO And CRO Market by Product
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Biopharmaceutical CMO And CRO Market Overview
10.4.2 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.4.3 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.4.4 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.4.5 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.4.6 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Biopharmaceutical CMO And CRO Market
10.4.6.1.1 South Africa Biopharmaceutical CMO And CRO Market by Source
10.4.6.1.2 South Africa Biopharmaceutical CMO And CRO Market by Service Type
10.4.6.1.3 South Africa Biopharmaceutical CMO And CRO Market by Product
10.4.6.2 Saudi Arabia Biopharmaceutical CMO And CRO Market
10.4.6.2.1 Saudi Arabia Biopharmaceutical CMO And CRO Market by Source
10.4.6.2.2 Saudi Arabia Biopharmaceutical CMO And CRO Market by Service Type
10.4.6.2.3 Saudi Arabia Biopharmaceutical CMO And CRO Market by Product
10.4.6.3 U.A.E Biopharmaceutical CMO And CRO Market
10.4.6.3.1 U.A.E Biopharmaceutical CMO And CRO Market by Source
10.4.6.3.2 U.A.E Biopharmaceutical CMO And CRO Market by Service Type
10.4.6.3.3 U.A.E Biopharmaceutical CMO And CRO Market by Product
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Biopharmaceutical CMO And CRO Market Overview
10.5.2 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.5.3 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.5.4 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.5.5 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.5.6 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Biopharmaceutical CMO And CRO Market
10.5.6.1.1 Brazil Biopharmaceutical CMO And CRO Market by Source
10.5.6.1.2 Brazil Biopharmaceutical CMO And CRO Market by Service Type
10.5.6.1.3 Brazil Biopharmaceutical CMO And CRO Market by Product
10.5.6.2 Argentina Biopharmaceutical CMO And CRO Market
10.5.6.2.1 Argentina Biopharmaceutical CMO And CRO Market by Source
10.5.6.2.2 Argentina Biopharmaceutical CMO And CRO Market by Service Type
10.5.6.2.3 Argentina Biopharmaceutical CMO And CRO Market by Product
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BIOPHARMACEUTICAL CMO AND CRO MARKET, KEY COMPANY PROFILES
12.1. AGC BIOLOGICS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A., INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. INNO BIO VENTURES SDN BHD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JRS PHARMA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. LONZA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PRA HEALTH SCIENCES, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PROBIOGEN AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. RENTSCHLER BIOPHARMA SE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SAMSUNG BIOLOGICS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AGC Biologics
2. Boehringer Ingelheim International GmbH
3. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
4. Inno Bio Ventures Sdn Bhd
5. JRS PHARMA
6. Lonza
7. PRA Health Sciences, Inc.
8. ProBioGen AG
9. Rentschler Biopharma SE
10. Samsung BioLogics